Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dror Michaelson

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Cancer|September 8, 2011
Combination of targeted agents in metastatic renal cell carcinoma: a path forward or a dead-end street?M Dror Michaelson
Cancer Treatment Reviews|March 21, 2007
ASCO 2006 highlights: targeted therapy for renal cell carcinomaM Dror Michaelson
Current Oncology Reports|April 2, 2003
The role of bisphosphonates in the management of metastatic prostate cancerM Dror Michaelson, Matthew R Smith
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Genitourinary malignanciesM Dror Michaelson, Matthew R Smith
Nature Reviews. Clinical Oncology|December 24, 2009
Targeted therapies: Sunitinib versus interferon-alpha in metastatic RCCJason E Faris, M Dror Michaelson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Bisphosphonates for treatment and prevention of bone metastasesM Dror Michaelson, Matthew R Smith
The Oncologist|January 24, 2012
Should the denosumab metastasis prevention trial change practice for men with nonmetastatic prostate cancer?Philip J Saylor, M Dror Michaelson
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
New treatments for renal cell carcinoma: targeted therapiesPhilip J Saylor, M Dror Michaelson
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Genitourinary malignanciesM Dror Michaelson, Matthew R Smith
Seminars in Oncology|August 27, 2013
Predictive markers in advanced renal cell carcinomaM Dror Michaelson, Walter M Stadler
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Cancer|September 8, 2011
Combination of targeted agents in metastatic renal cell carcinoma: a path forward or a dead-end street?M Dror Michaelson
Cancer Treatment Reviews|March 21, 2007
ASCO 2006 highlights: targeted therapy for renal cell carcinomaM Dror Michaelson
Current Oncology Reports|April 2, 2003
The role of bisphosphonates in the management of metastatic prostate cancerM Dror Michaelson, Matthew R Smith
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Genitourinary malignanciesM Dror Michaelson, Matthew R Smith
Nature Reviews. Clinical Oncology|December 24, 2009
Targeted therapies: Sunitinib versus interferon-alpha in metastatic RCCJason E Faris, M Dror Michaelson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Bisphosphonates for treatment and prevention of bone metastasesM Dror Michaelson, Matthew R Smith
The Oncologist|January 24, 2012
Should the denosumab metastasis prevention trial change practice for men with nonmetastatic prostate cancer?Philip J Saylor, M Dror Michaelson
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
New treatments for renal cell carcinoma: targeted therapiesPhilip J Saylor, M Dror Michaelson
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Genitourinary malignanciesM Dror Michaelson, Matthew R Smith
Seminars in Oncology|August 27, 2013
Predictive markers in advanced renal cell carcinomaM Dror Michaelson, Walter M Stadler
Pageof 13